{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:31:36Z","timestamp":1772155896855,"version":"3.50.1"},"reference-count":35,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,5]]},"abstract":"<title>ABSTRACT<\/title>\n<sec>\n<title>Objective:<\/title>\n<p>To document health advocacy strategies to influence public policies regulating new and emerging tobacco and nicotine products in Latin America and the Caribbean.<\/p>\n<\/sec>\n<sec>\n<title>Methods:<\/title>\n<p>We analyzed public documents on new and emerging tobacco and nicotine products including news sources and national legislation and interviewed public health advocates in Latin America and the Caribbean. The policy dystopia model was used to assess health advocacy strategies for regulation of these products.<\/p>\n<\/sec>\n<sec>\n<title>Results:<\/title>\n<p>Legislative activity on these products mostly occurred in Argentina, Brazil, Chile, Costa Rica, Colombia, Mexico, and Panama. Health advocates engaged in four action-based strategies to influence regulation of these products \u2013 coalition management, information management, direct involvement in and access to the policy process, and litigation. Health advocates concentrated on exposing industry deception and providing scientific evidence and country experiences. Health advocacy argument-based strategies exposed the increased use of new and emerging tobacco and nicotine products due to aggressive industry marketing. Advocates argued governments should comply with the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) obligations and its Conference of the Parties (COP) decisions to regulate these products.<\/p>\n<\/sec>\n<sec>\n<title>Conclusions:<\/title>\n<p>Applying the policy dystopia model on new and emerging tobacco and nicotine products provides a better understanding of how health advocates can pre-empt industry strategies to undermine WHO FCTC implementation. Unified transnational cooperative and coordinated health advocacy strategies to educate people can strengthen efforts. Promoting WHO FCTC obligations and COP decisions appears to support regulation on new and emerging tobacco and nicotine products and should be replicated elsewhere.<\/p>\n<\/sec>","DOI":"10.26633\/rpsp.2025.31","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T13:17:29Z","timestamp":1746451049000},"page":"1","source":"Crossref","is-referenced-by-count":1,"title":["Health advocacy strategies to influence policy-making on and regulation of new and emerging tobacco and nicotine products in Latin America and the Caribbean"],"prefix":"10.26633","volume":"49","author":[{"given":"Eric","family":"Crosbie","sequence":"first","affiliation":[{"name":"School of Public Health, University of Nevada Reno, Reno, NV, United States of America."},{"name":"ecrosbie@unr.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sierra","family":"Wilson","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Nevada Reno, Reno, NV, United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Tran","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Nevada Reno, Reno, NV, United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Albuquerque de Figueiredo","sequence":"additional","affiliation":[{"name":"Campaign for Tobacco-Free Kids, Washington, D.C., United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Severini","sequence":"additional","affiliation":[{"name":"Pan American Health Organization, Washington, D.C., United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianella","family":"Severini","sequence":"additional","affiliation":[{"name":"Campaign for Tobacco-Free Kids, Washington, D.C., United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto M.","family":"Sebri\u00e9","sequence":"additional","affiliation":[{"name":"Campaign for Tobacco-Free Kids, Washington, D.C., United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11167","reference":[{"key":"ref1","unstructured":"CDC Foundation, Truth Initiative. Monitoring E-cigarette trends in the United States urgent action needed to protect kids from flavored e-cigarettes. Atlanta, GA; CDC Foundation; 2024. Available at: https:\/\/tobaccomonitoring.org\/wp-content\/uploads\/2024\/11\/2024MonitoringE-CigaretteTrendsUS-1.pdf [cited 2024 Dec 26]."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Berg CJ, Melena A, Wittman FD, Robles T, Henriksen L. The reshaping of the e-cigarette retail environment: its evolution and public health concerns. Int J Environ Res Public Health. 2022;19(14):8518 https:\/\/doi.org\/10.3390\/ijerph19148518","DOI":"10.3390\/ijerph19148518"},{"key":"ref3","unstructured":"Grand View Research. Heated Tobacco Products Market Size, Share & Trends Analysis Report by Product (Stick, Leaf), by Distribution Channel (Online, Offline), by Region, and Segment Forecasts, 2019 - 2025, July 2022. Available at: https:\/\/www.grandviewresearch.com\/industry-analysis\/heated-tobacco- products-htps-market#:~:text=The%20global%20heated%20tobacco%20products,can%20be%20used%20multiple%20time [cited 2024 Nov 20]."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Jane Ling MY, Abdul Halim AFN, Ahmad D, Ahmad N, Safian N, Nawi AM. Prevalence and associated factors of e-cigarette use among adolescents in southeast Asia: a systematic review. Int J Environ Res Public Health. 2023;20(5):3883. https:\/\/doi.org\/10.3390\/ijerph20053883","DOI":"10.3390\/ijerph20053883"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Wang JB, Olgin JE, Nah G, Eric Vittinghoff E, Cataldo JK, Pletcher MJ, et al. Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health Eheart Study. PLoS One. 2018;13(7):e0198681. https:\/\/doi.org\/10.1371\/journal.pone.0198681","DOI":"10.1371\/journal.pone.0198681"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Goniewicz ML, Smith DM, Edwards KC, Blount BC, Caldwell KL, Feng J, et al. Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open. 2018;1(8):e185937. https:\/\/doi.org\/10.1001\/jamanetwork open.2018.5937","DOI":"10.1001\/jamanetworkopen.2018.5937"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bittoni MA, Carbone DP, Harris RE. Vaping, smoking and lung cancer risk. J Oncol Res Ther. 2024;9(3):10229. https:\/\/doi.org\/10.29011\/2574-710x.10229","DOI":"10.29011\/2574-710X.10229"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Xi Y, Yang L, Burtness B, Wang H. Vaping and tumor metastasis: current insights and progress. Cancer Metastasis Rev. 2024;44(1):4. https:\/\/doi.org\/10.1007\/s10555-024-10221-7","DOI":"10.1007\/s10555-024-10221-7"},{"key":"ref9","unstructured":"World Health Organization Framework Convention on Tobacco Control. Decision. Electronic nicotine delivery systems and electronic non-nicotine delivery systems. Geneva: WHO; 2016. Available at: https:\/\/iris.who.int\/handle\/10665\/371283 [cited: 2021 Apr 10]."},{"key":"ref10","unstructured":"World Health Organization Framework Convention on Tobacco Control. Decision. Novel and emerging tobacco products. Geneva: WHO; 2018. Available at: https:\/\/iris.who.int\/handle\/10665\/370546 [cited: 2021 Apr 10]."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Mathers A, Hawkins B, Lee K. Transnational tobacco companies and new nicotine delivery systems. Am J Public Health. 2019;109(2):227\u201335. https:\/\/doi.org\/10.2105\/AJPH.2018.304813.","DOI":"10.2105\/AJPH.2018.304813"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Crosbie E, Tran B, Albuquerque de Figueiredo B Severini L, Severini G, Sebri\u00e9 EM. Tobacco industry strategies to influence the regulation of new and emerging tobacco and nicotine Products in Latin America and the Caribbean. Rev Panam Salud Publica. 2024;48:e43. https:\/\/doi.org\/10.26633\/RPSP.2024.43","DOI":"10.26633\/RPSP.2024.43"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Legg T, Peeters S, Chamberlain P, Gilmore AB. The Philip Morris-funded Foundation for a Smoke-Free World: tax return sheds light on funding activities. Lancet. 2019;393(10190):2487\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(19)31347-9","DOI":"10.1016\/S0140-6736(19)31347-9"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Crosbie E, Severini G, Beem A, Tran B, Sebrie EM. New tobacco and nicotine products in Latin America and the Caribbean: assessing the market and regulatory environment. Tob Control. 2023;32(4):458\u201366. https:\/\/doi.org\/10.1136\/tobaccocontrol-2021-056959","DOI":"10.1136\/tobaccocontrol-2021-056959"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Crosbie E, Sebrie EM, Glantz SA. strong advocacy led to successful implementation of smokefree Mexico City. Tob Control. 2011;20(1):64\u201372. https:\/\/doi.org\/10.1136\/tc.2010.037010","DOI":"10.1136\/tc.2010.037010"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Crosbie E, Sosa P, Glantz SA. The importance of continued engagement during the implementation phase of tobacco control policies in a middle-income country: the case of Costa Rica. Tob Control. 2017;26(1):60\u20138. https:\/\/doi.org\/10.1136\/tobaccocontrol-2015-052701","DOI":"10.1136\/tobaccocontrol-2015-052701"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Crosbie E, Sosa P, Glantz SA. Defending strong tobacco packaging and labelling regulations in Uruguay: transnational tobacco control network versus Philip Morris International. Tob Control. 2018;27(2):185\u201394. https:\/\/doi.org\/10.1136\/tobaccocontrol-2017-053690","DOI":"10.1136\/tobaccocontrol-2017-053690"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Crosbie E, Perez S, Cortez Copa P, Monje AKG, Machin N, Lopez G, et al. Tobacco control in Bolivia: transnational civil society efforts in securing a comprehensive law. Nicotine Tob Res. 2022;24(8):1300\u20134. https:\/\/doi.org\/10.1093\/ntr\/ntac036","DOI":"10.1093\/ntr\/ntac036"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Crosbie E, Edison K, Maclean V, Dereje Moges D, Fuss C, Muggli ME, et al. Adopting a WHO Framework Convention on Tobacco Control-based tobacco control law in Ethiopia: sustained transnational health advocacy and multi-sectoral institutionalized support. Int J Environ Res Public Health. 2024;21(3). https:\/\/doi.org\/10.3390\/ijerph21030280","DOI":"10.3390\/ijerph21030280"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Jankowski M, Brozek GM, Lawson J, Skoczy\u0144ski S, Majek P, Zejda JE. New ideas, old problems? Heated tobacco products \u2013 a systematic review. Int J Occup Med Environ Health. 2019;32(5):595\u2013634. https:\/\/doi.org\/10.13075\/ijomeh.1896.01433","DOI":"10.13075\/ijomeh.1896.01433"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Hartmann-Boyce J, McRobbie H, Lindson N, Bullen C, Begh R, Theodoulou A, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2020;10(10):CD010216. https:\/\/doi.org\/10.1002\/14651858.CD010216.pub4","DOI":"10.1002\/14651858.CD010216.pub"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Fadus MC, Smith TT, Squeglia LM. The rise of e-cigarettes, pod mod devices, and juul among youth: factors influencing use, health implications, and downstream effects. Drug Alcohol Depend. 2019;201:85\u201393. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.04.011","DOI":"10.1016\/j.drugalcdep.2019.04.011"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Malone RE, Balbach ED. tobacco industry documents: treasure trove or quagmire? Tob Control. 2000;9(3):334\u20138. https:\/\/doi.org\/10.1136\/tc.9.3.334","DOI":"10.1136\/tc.9.3.334"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Ulucanlar S, Fooks GJ, Gilmore AB. The policy dystopia model: an interpretive analysis of tobacco industry political activity. PLoS Med. 2016;13(9):e1002125. https:\/\/doi.org\/10.1371\/journal.pmed.1002125","DOI":"10.1371\/journal.pmed.1002125"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Bhatta DN, Crosbie E, Bialous SA, Glantz S. Defending comprehensive tobacco control policy implementation in Nepal from tobacco industry interference (2011\u20132018). Nicotine Tob Res. 2020;22(12):2203\u201312. https:\/\/doi.org\/10.1093\/ntr\/ntaa067","DOI":"10.1093\/ntr\/ntaa067"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Uang R, Crosbie E, Glantz SA. Tobacco control law implementation in a middle-income country: transnational tobacco control network overcoming tobacco industry opposition in Colombia. Glob Public Health. 2018;13(8):1050\u201364. https:\/\/doi.org\/10.1080\/17441692.2017.1357188","DOI":"10.1080\/17441692.2017.1357188"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Zatonksi M, Brandt A. Divide and conquer? E-cigarettes as a disruptive technology in the history of tobacco control. In: Gruszczynski L, editor. The regulation of e-cigarettes: international, European and national challenges. Cheltenham: Edward Elgar Publishing Ltd; 2019.","DOI":"10.4337\/9781788970464.00010"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Meyer ML, Peters S, Mok TS, Lam S, Yang PC, Aggarwal C, et al. Lung cancer research and treatment: global perspectives and strategic calls to action. Ann Oncol. 2024;35(12):1088\u2013104. https:\/\/doi.org\/10.1016\/j.annonc.2024.10.006","DOI":"10.1016\/j.annonc.2024.10.006"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Gilmore AB, Fooks G, Drope J, Bialous SA, Jackson RR. Exposing and addressing tobacco industry conduct in low-income and middle-income countries. Lancet. 2015;385(9972):1029\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(15)60312-9","DOI":"10.1016\/S0140-6736(15)60312-9"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Lee S, Ling PM, Glantz SA. The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries. Cancer Causes Control. 2012;23(Suppl 1):117\u201329. https:\/\/doi.org\/10.1007\/s10552-012-9914-0","DOI":"10.1007\/s10552-012-9914-0"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Hiilamo H, Glantz SA. Implementation of effective cigarette health warning labels among low-and middle-income countries: state capacity, path-dependency and tobacco industry activity. Soc Sci Med. 2015;124:241\u20135. https:\/\/doi.org\/10.1016\/j.socscimed.2014.11.054","DOI":"10.1016\/j.socscimed.2014.11.054"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Crosbie E, Gutkowski P, Severini G, Pizarro ME, Perez S, Albuquerque de Figueiredo B,et al. Progress in adopting bans on tobacco advertising, promotion, and sponsorship in the Americas: lessons from Uruguay and Argentina. Rev Panam Salud Publica. 2022;46:e102. https:\/\/doi.org\/10.26633\/RPSP.2022.102","DOI":"10.26633\/RPSP.2022.102"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Ezeilo CO, Leon N, Jajodia A, Han HR. Use of social media for health advocacy for digital communities: descriptive study. JMIR Form Res. 2023;7:e51752. https:\/\/doi.org\/10.2196\/51752","DOI":"10.2196\/51752"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Zatonski MZ, Egbe CO, Robertson L, Gilmore A. Framing the policy debate over tobacco control legislation and tobacco taxation in South Africa. Tob Control. 2023;32(4):450\u20137. https:\/\/doi.org\/10.1136\/tobaccocontrol-2021-056675","DOI":"10.1136\/tobaccocontrol-2021-056675"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Jackson M, Brennan L, Parker L. The public health community\u2019s use of social media for policy advocacy: a scoping review and suggestions to advance the field. Public Health. 2021;198:146\u201355. https:\/\/doi.org\/10.1016\/j.puhe.2021.07.015","DOI":"10.1016\/j.puhe.2021.07.015"}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/66385\/v49e312025.pdf?sequence=1&isAllowed=y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T13:17:40Z","timestamp":1746451060000},"score":1,"resource":{"primary":{"URL":"https:\/\/iris.paho.org\/handle\/10665.2\/66385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":35,"alternative-id":["RPSP.2025.31"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2025.31","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]}}}